Moda Bio

Developer of immunometabolism-based drugs for immune diseases

placeShenzhen, Guangdong Province, China calendar_todayFounded 2021 language metabiopharma.com

Social engagement

Social engagement: 306 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include ForceField, XtalPi, IMO Ventures, Tiantu Capital.

Investor typeCountShare
Venture capital550%
Private equity110%
Other / undisclosed440%

Recent activity

15 Oct 2025
Milestone
regulatory
Coming soon